Underreporting affects COVID-19 data, experts say
Underreporting affects COVID-19 data, experts say

Underreporting affects COVID-19 data, experts say

ORLANDO, Fla. The BA.2 variant is spreading across the United States, and doctors say it is causing a slight increase in COVID-19 cases.

Professor of Epidemiology at the University of Washington, Dr. Ali Mokdad, said the omicron subvariant is more contagious, but that is not a cause for concern.

“This increase is primarily due to change in behavior,” Mokdad said.

[TRENDING: ‘Pace clocking’ used to catch speeders in Florida. Trooper Steve explains | Joel Greenberg’s estranged wife appears in Matt Gaetz rap video | Become a News 6 Insider (it’s free!)]

Ad

More people are starting to travel and gather indoors. Fewer people wear masks.

Mokdad said about 25% of the population wears face clothing around the United States, the lowest since April 2020.

“Due to changes in behavior and weaning immunity from vaccines and previous infections, many people are susceptible and become infected,” Mokdad said.

Of all the people who become infected with the virus, these numbers are not reflected in the COVID-19 data.

Mokdad said it is because many people are asymptomatic and others do not do their due diligence.

“A lot of people right now are testing themselves at home using these home tests and they are not going to go and report it to the county,” Mokdad said.

Although the number of cases may be lower than it should be, Mokdad said the incomplete data does not mask a large increase.

“We are slowing down. It is not because we are reporting because COVID-19 infections are slowing down in our society,” Mokdad said.

Ad

He said it could change as we approach winter.

“All of us there [have] got a vaccine or booster, five months after, if we do not get a new booster, we are susceptible to being infected, ”said Mokdad.

He said before the winter that we need another vaccine. If not, he expects an increase. At that time, a new test method may be available to patients.

The Food and Drug Administration has granted an emergency use permit for a new COVID-19 test. It’s called InspectIR COVID-19 breathalyzer. It can detect infections with a breath test and the device can give results in about three minutes.

In a study of 2,409 people with and without symptoms, the FDA said the device detected 91.2% of cases.

The FDA, after receiving positive results from the unit, suggests that patients follow a molecular test.

Ad

The device can be used in hospitals, doctors’ offices and at mobile test sites.

The FDA said the company can produce about 100 instruments each week.

Copyright 2022 by WKMG ClickOrlando – All rights reserved.

Leave a Reply

Your email address will not be published.